Noah Holmes

Noah Holmes has a diverse work experience in the pharmaceutical industry. Noah is currently working as the Sr. Director of Trade and Patient Support at Mycovia Pharmaceuticals since December 2021. Prior to this, Noah held senior positions at Relypsa, where they were the Senior Director of Patient Access Services from August 2015 to December 2021, and the Director of Patient Access Services from August 2015 to August 2017. At Relypsa, they successfully launched and managed a HUB program for a drug called VELTASSA, and also oversaw the Channel and Trade function. Before Relypsa, Noah worked at GSK as the Director of Reimbursement and Patient Assistance for NUCALA from July 2014 to August 2015, and as the Director of Brand Payer Strategy for Rare Diseases from April 2012 to July 2014. At GSK, they led market access strategies for various therapies, including gene and oligonucleotide therapies for rare diseases. Prior to GSK, Noah held roles at Xcenda as the Associate Director of Reimbursement Strategy and Health Policy from 2008 to June 2010, and as the Assistant Director of Reimbursement Strategy and Commercialization from September 2007 to September 2008. Noah also worked at Lash Group, where they served as the Manager of Reimbursement Consulting from September 2006 to September 2007, Analyst of Reimbursement Consulting from September 2005 to September 2006, and as a Sr. Reimbursement Counselor from September 2003 to September 2005.

Noah Holmes earned a Bachelor of Arts degree from Winthrop University.